were not yet established; Michael Smith first described tigations of simple, basic questions can still lead to new site-directed mutagenesis in 1978, and the polymerase and important discoveries. Finally, this work is a testachain reaction was not described until the work of Karey ment to the power of a carefully crafted, unselfish collabMullis in 1985 (1993 Nobel Prize in Chemistry). In short, oration. While none of the work cited in this Prize was our knowledge of the intrinsic pathways of protein degpublished in "flashy" journals, it set the stage for subseradation was minimal, the breadth and impact were unquent detailed and influential work by these and other suspected, and the tools to divine the details were investigators, perhaps most notably Alexander Varshavlacking. sky. As outlined briefly below, we have learned much Still, by the mid 70s several investigators had become about the role of protein metabolism from these subseinterested in the question: why does intracellular protequent studies.
ing individual components. This unbiased approach ment. Finally, his altruism in hosting Hershko and his helped him to appreciate the uniqueness of the system students each summer was a testament to his exciteand avoided the pitfalls of setting out to isolate THE ment and commitment to understanding the system. protease. He assembled a team that was energetic and Hershko and Rose first met at a Fogarty Foundation enthusiastic in the pursuit of this goal. He found remeeting in 1977. As they spoke, they both realized their sources and sage advice, as well as an unmistakable mutual interests in ATP-dependent proteolysis, and creativity in his collaboration with Rose. He worked hard Rose invited Hershko to do a sabbatical in his laboratory to educate his peers concerning the likely relevance of at the Institute for Cancer Research in Philadelphia. This the pathway to physiological regulation and struggled, lucky coincidence joined these two talented investigaultimately successfully, to develop a large number of tors in the collaboration that would define the basis of assays that convinced the skeptics amongst us that ATP-dependent protein degradation and frame a new ubiquitination was the targeting event of intracellular means of viewing cellular regulation. ATP-dependent proteolysis.
Aaron Ciechanover obtained his M.D. degree in 1974
The Early Days from Hebrew University-Hadassah Medical School and Perhaps the first challenge in dissecting this system was completed his mandatory military service before joining the development of an assay. In exmentor and I am still awe-struck by his creativity. He periments conducted in both Haifa and Philadelphia, has a sense of how things should work, and it was often they then purified the single required component from the job of those that worked with him to figure out how the flow through and showed it was a heat stable polyto test his visions. He is also one of the most selfless peptide of about 9 kDa. They called this protein APF-1 scientists I know. It was often enough for him to answer for ATP-dependent proteolysis factor 1. This began a the question; it was not really important to him that he remarkable series of publications, in close collaboration received credit. Thus, his real contributions to the field with Ernie Rose and several of his postdoctoral fellows. have only recently been widely recognized. I know that Much of this work was accomplished in Philadelphia the majority of the assays used were his creative contriduring annual visits of Hershko and his student Ciechabutions. The ATP:PP i exchange assay used to define E1 nover to the Rose laboratory. activity came directly out of his enzymological bag of Fractionation of the retained protein fractions (fraction tricks. Covalent chromatography to purify the E1 was II) was next reported by Hershko, Ciechanover, and his laboratory's creation. Use of nonreducing PAGE to Rose (Hershko et al., 1979) . Gel filtration revealed a high reveal thiol intermediates in the pathway, the reduction molecular weight fraction that was stabilized by ATP of these intermediates, and the discovery of deubiquitinating enzymes are directly attributable to his involve-(APF-2). Although it was not recognized at the time, the effect of ATP on stability is almost certainly due to the 1981). They also provided further evidence that this instabilization of the proteasome by ATP. However, intertermediate rearranged to a thiol ester. The C-terminal pretations at the time centered on the possibility that glycine was the site of adenylation (Haas et al., 1983) this was a protein kinase, or possibly a protease related as it is in ubiquitination of histone H2a. Based on this to the ATP-dependent bacterial recA. The next seminal knowledge, the ubiquitin-activating enzyme (E1) was puobservation came when Ciechanover and several techrified using an ingenious affinity chromatography apnicians in Hershko's lab showed that APF-1 formed proach , 1982) . He also pointed out that the inability system: a small protein was covalently coupled to putato demonstrate ATP-dependent proteolysis in many lytive substrates (requiring ATP) and then degraded by a sates stemmed from the proteolytic inactivation of ubiproteolytic activity that required a large protein complex.
quitin by lysosomal proteases, underscoring the fortuIt was at this point that I began to work on the system. show that it was K48-linked polyubiquitin that targeted defective in ubiquitination and selective protein degraproteins for degradation (Chau et al., 1989) . His laboradation at the nonpermissive temperatures. This pair of tory also used this assay, degradation of ␤-galactosipapers clearly established for the first time that the ubidase, to clone and characterize members of the UBP quitin system was the major pathway of cellular proteolfamily of deubiquitinating enzymes that removed the ysis and verified by an independent approach that ubifused ubiquitin (Baker et al., 1992) . This is a truly a quitination was vital. remarkable body of work that both validated the pioSince ts85 cells showed a cell cycle defect, it also neering biochemical studies of Hershko, Ciechanover, suggested that proteolysis was important for cell cycle and Rose and brought a whole new array of tools and control. We now know that the precisely timed ubiquitiknowledge of the physiological significance of ubiquitination and degradation of regulatory molecules is necnation. essary for progression through the cell cycle. Later investigators used these cell lines to demonstrate the Context and Generality of Ubiquitination participation of the ubiquitin proteasome system in antiIt is remarkable that it took so long to discover ubiquitigen presentation and to demonstrate that the degradanation and that it has been so well defined in the last tion of a number of cellular targets was enabled by 25 years. In a short period from 1978 to 1985, the system ubiquitination. Ubiquitin-mediated proteolysis has since of ubiquitination was biochemically defined by the efbecome a central dogma in a variety of pathways.
forts of Ciechanover, Hershko, and Rose, largely with At this point, Varshavsky became convinced that to model substrates. From 1984 to 1990, Varshavsky and understand ubiquitination a genetic approach was rehis colleagues confirmed and expanded the biochemical quired and that yeast was the organism of choice for findings with their groundbreaking genetic studies. The this study. The importance of this approach cannot be discovery of ubiquitination is, on its own, sufficient to overemphasized. Not only did it reveal new components justify the Nobel Prize, but time has proven that the of the pathway that would have never been identified conjugation of small proteins to larger targets is a genby conventional biochemistry, but it also validated the eral method of directing such targets to precise cellular biochemical work and elucidated the physiological siglocalizations and fates. Thus, there are a large number nificance of the pathways. In the years from 1984 to 1989 of ubiquitin-like proteins that have the ubiquitin fold, Varshavsky and many talented postdoctoral fellows laid that are activated and conjugated by enzymatic machinthe foundation for our current understanding of the comery that is evolutionarily related to that used by ubiquitin, binatorial nature of ubiquitination and thus its specificity.
and that once conjugated result in altered protein localOne of the first fruits of this approach was a landmark ization or function (Schwartz and Hochstrasser, 2003) . paper by Andreas Bachmair, Finley, and Varshavsky that
The covalent attachment of a ubiquitin-like domain to described the "N-end rule" (Bachmair et al., 1986) . When a larger protein can be viewed as a general localization ubiquitin was fused to ␤-galactosidase and expressed signal, with localization to the proteasome as simply the in yeast, they noticed that the ubiquitin was rapidly rebest understood example. moved by deubiquitinating enzymes to reveal a new N We are now poised to take advantage of our knowlterminus. Because of the relatively lax specificity of edge of this system. As new substrates and pathologies DUBs for amino acids in the PЈ position, almost any that result from aberrations in the pathway become amino acid could be positioned at the N terminus and known, the opportunities to develop pharmaceuticals there was a huge difference in the degradation rate of are enormous. Already, proteasome inhibitors are makthe resultant ␤-galactosidase, depending on the identity ing their way into clinical practice with the approval of of the newly exposed N-terminal amino acid. On the Velcade for treatment of multiple myeloma. It seems strength of this example, they postulated that the halflikely that many more opportunities will present themlife of a protein could be determined by the identity of the N-terminal residue. This single observation was selves as we discover more specific inhibitors that can
